Ranolazine

NDC 68462-320 · Glenmark Pharmaceuticals Inc., USA

Generic nameRANOLAZINE

Dosage formTABLET, FILM COATED, EXTENDED RELEASE

RouteORAL

Active ingredient(s)RANOLAZINE

Strength1000 mg/1

Pharmacologic classAnti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]

Marketing categoryANDA

Packages

68462-320-05 — 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-320-05)

68462-320-60 — 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-320-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60290-056 — Ranolazine, 60687-549 — Ranolazine, 63304-017 — Ranolazine, 63304-018 — Ranolazine, 63629-4874 — Ranolazine, 67877-525 — Ranolazine, 67877-526 — Ranolazine, 68180-354 — RANOLAZINE, 68180-355 — RANOLAZINE, 68462-319 — RANOLAZINE, 69367-293 — Ranolazine, 69367-294 — Ranolazine, 70625-206 — RANOLAZINE, 70625-207 — RANOLAZINE, 70756-703 — Ranolazine, 70756-704 — Ranolazine, 70771-1499 — Ranolazine, 70771-1500 — Ranolazine, 71205-867 — Ranolazine, 71205-868 — Ranolazine, +34 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels